From July 1, 2023 to February 8, 2024, the company has repurchased 6,634,161 shares, representing 2.4% for $15.68 million. With this, the company has completed the repurchase of 19,429,491 shares, representing 6.88% for $50 million under the buyback announced on May 5, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
218 GBX | +2.59% | +5.57% | +12.26% |
Apr. 25 | Transcript : PureTech Health plc, 2023 Earnings Call, Apr 25, 2024 | |
Apr. 25 | PureTech touts "momentum" as grants shrivel but annual loss narrows | AN |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.26% | 734M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- PRTC Stock
- News PureTech Health plc
- Tranche Update on PureTech Health plc's Equity Buyback Plan announced on May 5, 2022.